Kejal Patel is Vice President, Clinical Operations of Sudo Biosciences, bringing deep expertise in clinical operations strategy and a strong track record of delivering programs from early development through late stage execution. Prior to Sudo, she was Director of Clinical Operations at Stargazer Pharmaceuticals, where she led the operational strategy and execution of a global Phase 2b pivotal study in a rare disease indication. Kejal previously held senior clinical operations leadership roles across a broad range of therapeutic areas at Outpost Medicine and Takeda, where she led large global Phase 3 programs and cross-functional teams.

Kejal holds an MSc from University College London and a BSc (Hons) from Brunel University.